Lv1
50 积分 2025-11-24 加入
An FDA oncology analysis of CD3 bispecific constructs and first-in-human dose selection
1天前
已完结
Current understanding and management of CAR T cell-associated toxicities
15天前
已完结
An FDA analysis of clinical hold deficiencies affecting investigational new drug applications for oncology products
20天前
已完结
The T-cell-dependent antibody response assay in nonclinical studies of pharmaceuticals and chemicals: Study design, data analysis, interpretation
2个月前
已完结
Supporting an integrated QTc risk assessment using the hERG margin distributions for three positive control agents derived from multiple laboratories and on multiple occasions
2个月前
已完结
Deuterium in drug discovery: progress, opportunities and challenges
3个月前
已完结
The Application of Deuteration Strategy in Drug Design
3个月前
已完结
The cotton rat (Sigmodon hispidus) as an animal model for respiratory tract infections with human pathogens
3个月前
已完结
Nonclinical Vehicle Use in Studies by Multiple Routes in Multiple Species
3个月前
已完结
Tolerable Levels of Nonclinical Vehicles and Formulations Used in Studies by Multiple Routes in Multiple Species With Notes on Methods to Improve Utility
3个月前
已完结
皖公网安备34019202002308
